ATE361469T1 - Methoden zur introduktion heterologer zellen in fische - Google Patents

Methoden zur introduktion heterologer zellen in fische

Info

Publication number
ATE361469T1
ATE361469T1 AT99965950T AT99965950T ATE361469T1 AT E361469 T1 ATE361469 T1 AT E361469T1 AT 99965950 T AT99965950 T AT 99965950T AT 99965950 T AT99965950 T AT 99965950T AT E361469 T1 ATE361469 T1 AT E361469T1
Authority
AT
Austria
Prior art keywords
cells
methods
fish
useful
introduction
Prior art date
Application number
AT99965950T
Other languages
English (en)
Inventor
George N Serbedzija
Carlos E Semino
Patricia Mcgrath
Original Assignee
Phylonix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phylonix Pharmaceuticals Inc filed Critical Phylonix Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE361469T1 publication Critical patent/ATE361469T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/40—Fish
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4603—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Environmental Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Husbandry (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
AT99965950T 1998-12-01 1999-11-30 Methoden zur introduktion heterologer zellen in fische ATE361469T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11046498P 1998-12-01 1998-12-01

Publications (1)

Publication Number Publication Date
ATE361469T1 true ATE361469T1 (de) 2007-05-15

Family

ID=22333153

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99965950T ATE361469T1 (de) 1998-12-01 1999-11-30 Methoden zur introduktion heterologer zellen in fische
AT07008609T ATE428928T1 (de) 1998-12-01 1999-11-30 Verfahren zur einführung von heterologischen zellen in fische

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT07008609T ATE428928T1 (de) 1998-12-01 1999-11-30 Verfahren zur einführung von heterologischen zellen in fische

Country Status (9)

Country Link
US (4) US6761876B2 (de)
EP (1) EP1135531B1 (de)
JP (1) JP4522587B2 (de)
AT (2) ATE361469T1 (de)
AU (1) AU776246B2 (de)
CA (1) CA2352568A1 (de)
DE (2) DE69940753D1 (de)
ES (2) ES2286908T3 (de)
WO (1) WO2000032822A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU776246B2 (en) 1998-12-01 2004-09-02 Phylonix Pharmaceuticals, Inc. Methods for introducing heterologous cells into fish
JP5138867B2 (ja) * 2002-08-01 2013-02-06 イミューノメディクス、インコーポレイテッド α−フェトタンパク質Ｉｍｍｕ３１抗体および融合タンパク質ならびにその使用方法
GB0228093D0 (en) * 2002-12-02 2003-01-08 Daniolabs Ltd Disease models and uses thereof
US20070044168A1 (en) * 2005-07-12 2007-02-22 Northwestern University Transplantable tumor model
MY160388A (en) 2009-10-07 2017-03-15 Kerecis Ehf A scaffold material for wound care and/or other tissue healing applications
JP5875010B2 (ja) * 2012-10-24 2016-03-02 国立大学法人三重大学 異種細胞移植モデル動物の作製方法
EP2925890B1 (de) * 2012-12-02 2024-05-15 BioMedCore Inc. Beschleunigte vorhersage einer krebsprogression und einer behandlungsreaktion
KR101508356B1 (ko) 2013-05-06 2015-04-06 광주과학기술원 제브라피시 인간 종양 이종이식 모델을 이용한 항암제 스크리닝 방법
WO2015006455A1 (en) * 2013-07-10 2015-01-15 The General Hospital Corporation Immune-compromised zebrafish
CN107406838A (zh) 2014-11-06 2017-11-28 纳幕尔杜邦公司 Rna引导的内切核酸酶向细胞中的肽介导的递送
WO2016106295A1 (en) * 2014-12-22 2016-06-30 Dana-Farber Cancer Institute, Inc. In vivo methods for identifying cancer-associated immunotherapy targets
JP6622007B2 (ja) * 2015-05-29 2019-12-18 オリンパス株式会社 細胞評価方法
EP3370518B1 (de) 2015-10-14 2023-08-23 X-Therma, Inc. Zusammensetzungen und verfahren zur verringerung der eiskristallbildung
EP3387134B1 (de) 2015-12-11 2020-10-14 Danisco US Inc. Verfahren und zusammensetzungen für verbesserte nukleasevermittelte genommodifizierung und verringerte off-target-nebenwirkungen
DK3390631T3 (da) 2015-12-18 2020-07-13 Danisco Us Inc Fremgangsmåder og sammensætninger til t-rna-baseret guide-rna-ekspression
CN108967358A (zh) * 2018-05-31 2018-12-11 上海交通大学医学院附属瑞金医院 一种斑马鱼fl肿瘤模型的构建方法及其应用
CN112452362B (zh) * 2020-09-25 2021-09-21 中山大学 一种无泵固定斑马鱼微流体芯片***及其制备方法与应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5399992A (en) 1977-02-10 1978-08-31 Hitachi Ltd Water quality fluctuation detector
ZA793568B (en) 1978-07-26 1981-02-25 Duphar Int Res Algicidal composition
GB2080948B (en) 1980-08-04 1983-09-21 Euratom Apparatus and method for measuring the toxicity of pollutants to aquatic living organisms
US4816392A (en) 1984-10-02 1989-03-28 Research Corporation Of The University Of Hawaii Rapid stick test for detection of ciguatoxin and other polyether toxins from tissues
US5510099A (en) 1987-05-01 1996-04-23 Stratagene Mutagenesis testing using transgenic non-human animals carrying test DNA sequences
DE3801476A1 (de) 1988-01-20 1989-08-03 Henkel Kgaa Zusammensetzungen zur befreiung festgesetzter bohrgestaenge
US5190920A (en) 1990-09-24 1993-03-02 W. R. Grace & Co.-Conn. Method for using synthetic analogs of thrombospondin for inhibiting metastasis activity
US5326692B1 (en) 1992-05-13 1996-04-30 Molecular Probes Inc Fluorescent microparticles with controllable enhanced stokes shift
US5658751A (en) 1993-04-13 1997-08-19 Molecular Probes, Inc. Substituted unsymmetrical cyanine dyes with selected permeability
EP0703990A4 (de) 1993-04-30 1997-09-24 Lxr Biotechnology Inc Verfahren zur erkennung potentiell therapeutisch wirksamer mittel und dafur verwendbare zellinien
US5565187A (en) 1993-06-01 1996-10-15 Zikria; Bashir Methods for studying capillary circulation using fish fry and tadpoles
US5491084A (en) 1993-09-10 1996-02-13 The Trustees Of Columbia University In The City Of New York Uses of green-fluorescent protein
DE4401868C1 (de) 1994-01-22 1995-02-16 Lobbe Xenex Gmbh Mikrobielles Verfahren zum Nachweis von Schadstoffen
WO1996003034A1 (en) 1994-07-27 1996-02-08 Massachusetts Institute Of Technology Method for retroviral vector insertion in fish
FR2728790B1 (fr) 1994-12-29 1997-01-24 Cird Galderma Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial
US5981218A (en) * 1995-08-09 1999-11-09 Bristol-Myers Squibb Company Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis and encoded polypeptides
US5932418A (en) 1996-04-08 1999-08-03 Naiad Systems, Inc. Fish embryo screening test for genotoxic agents using three different developmental life stages
GB9615202D0 (en) 1996-07-19 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
GB9701245D0 (en) 1997-01-22 1997-03-12 Eisai Co Ltd Method of screening compounds
DE19726597C1 (de) * 1997-06-23 1998-11-19 Wengler Georg S Verfahren zur Herstellung von monoklonalen Antikörper
AU776246B2 (en) 1998-12-01 2004-09-02 Phylonix Pharmaceuticals, Inc. Methods for introducing heterologous cells into fish
EP1826560B1 (de) 1998-12-01 2009-04-15 Phylonix Pharmaceuticals Inc. Verfahren zur Einführung von heterologischen Zellen in Fische

Also Published As

Publication number Publication date
ATE428928T1 (de) 2009-05-15
ES2286908T3 (es) 2007-12-01
WO2000032822A1 (en) 2000-06-08
DE69935999T2 (de) 2008-01-10
JP4522587B2 (ja) 2010-08-11
CA2352568A1 (en) 2000-06-08
EP1135531B1 (de) 2007-05-02
US20110286973A1 (en) 2011-11-24
AU2161200A (en) 2000-06-19
AU776246B2 (en) 2004-09-02
US6761876B2 (en) 2004-07-13
US20020061291A1 (en) 2002-05-23
US20070130632A1 (en) 2007-06-07
JP2002531104A (ja) 2002-09-24
US20040185431A1 (en) 2004-09-23
EP1135531A4 (de) 2005-03-09
ES2325285T3 (es) 2009-08-31
DE69935999D1 (de) 2007-06-14
EP1135531A1 (de) 2001-09-26
US7408095B2 (en) 2008-08-05
US7838726B2 (en) 2010-11-23
DE69940753D1 (de) 2009-05-28

Similar Documents

Publication Publication Date Title
ATE361469T1 (de) Methoden zur introduktion heterologer zellen in fische
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
NZ333830A (en) Method for assessing chemosensitivity of a biopsy sample
ATE266723T1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
WO2003066072A3 (en) Cell therapy using immunoregulatory t-cells
DE69940507D1 (de) Biotechnisch erzeugte gefässprothese für die implantation
DE50011820D1 (de) Verfahren zur kultivierung von krebszellen aus humangewebe und vorrichtung zur aufbereitung von gewebeproben
BR0209083A (pt) Métodos e reagentes para transplante celular
BR0312764A (pt) Cardiomiócitos funcionais originados de células-tronco embrionárias humanas
ATE307902T1 (de) Methoden und testsätze zur probennahme und aufbewahrung von biologischen proben
NO20052949L (no) Implantat inneholdende dyrkede bruksceller og fremgangsmate for fremstilling
DE69634982D1 (de) Verfahren zur steigerung von hematopoietischen zellen
RS20100249A (en) CONJUGATES AND PROCEDURES FOR THEIR PRODUCTION, AND THEIR USE FOR THE TRANSPORT OF MOLECULES THROUGH BIOLOGICAL MEMBRANE
DE60140536D1 (de) Verfahren zur gewinnung von muskelnabstammenden zellpopulationen und deren verwendung
ATE321843T1 (de) Zellen, kulturverfahren, und ihre verwendung in autologer transplantationstherapie
ATE222122T1 (de) Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen
ATE392469T1 (de) Verfahren zur ex vivo bildung von säugetier- knochen und dessen verwendungen
CA2517140A1 (en) Use of pc-cell derived growth factor (pcdgf) for increasing the proliferation of b cells
EP1826560A3 (de) Verfahren zur Einführung von heterologischen Zellen in Fische
ATE384121T1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen
DE69934399D1 (de) Komplex aus peptid und mhc-peptid auf oberfläche von phagen
TR200100175T2 (tr) Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
DE69807327D1 (de) Methode zur steigerung der überlebung transplantierter zellen
DE69916302D1 (de) Verwendung von dendritischen zellen-depletierten zusammensetzungen zur verbesserung der transplantation von allogenen hämatopoietischen zellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties